How Gut Bacteria May Influence Colorectal Cancer

For a long time, colorectal cancer (CRC) was primarily viewed as a genetic disease.

However, research now reveals that our gut microbiome plays a critical role in its development.

A healthy gut maintains balance, but "dysbiosis"—an imbalance of bacteria—can trigger cancer.

Scientists often describe a "driver-passenger" model: certain bacteria act as "drivers" by damaging DNA directly or causing inflammation, while others "passenger" bacteria thrive in the resulting tumor environment.

Species like Fusobacterium nucleatum are frequently found in CRC tumors, where they may promote tumor growth and even make chemotherapy less effective.

Importantly, some bacteria produce beneficial compounds like butyrate, which protect the gut, while others generate harmful metabolites.

This discovery is changing medicine.

Furthermore, future treatments may involve "microbial profiling" to personalize therapies, potentially using diet, probiotics, or even fecal transplants to restore gut health.

By understanding the microbial ecosystem within us, we are unlocking new ways to prevent, detect, and treat colorectal cancer more effectively than ever before.